Ocular Therapeutix, Inc. provided earnings guidance for the second quarter ended June 30, 2021. The company is reporting preliminary second quarter 2021 total net product revenue of approximately $11.7 million, representing a greater than 600% year-over-year increase versus the second quarter 2020 and an approximately 60% sequential increase over the first quarter of 2021.